Back to Search
Start Over
Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma.
- Source :
-
Annals of hematology [Ann Hematol] 2020 Feb; Vol. 99 (2), pp. 379-380. Date of Electronic Publication: 2019 Dec 10. - Publication Year :
- 2020
- Subjects :
- Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Dexamethasone administration & dosage
Drug Substitution
Febrile Neutropenia etiology
Granulocyte Colony-Stimulating Factor therapeutic use
Humans
Immunologic Factors administration & dosage
Lenalidomide administration & dosage
Male
Multiple Myeloma complications
Piperacillin, Tazobactam Drug Combination therapeutic use
Pyoderma Gangrenosum drug therapy
Pyoderma Gangrenosum therapy
Thalidomide analogs & derivatives
Thalidomide therapeutic use
Immunologic Factors adverse effects
Lenalidomide adverse effects
Multiple Myeloma drug therapy
Pyoderma Gangrenosum chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 1432-0584
- Volume :
- 99
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Annals of hematology
- Publication Type :
- Report
- Accession number :
- 31822948
- Full Text :
- https://doi.org/10.1007/s00277-019-03846-0